Biotechnology Amarin to Report Second Quarter 2022 Financial Results and Host Conference Call on August 3, 2022 July 20, 2022
Biotechnology Apellis Pharmaceuticals, Inc. (APLS) Moves 16.3% Higher: Will This Strength Last? July 20, 2022
Biotechnology FibroGen Shareholder Alert: Shareholder Class Action Survives in Part Motion to Dismiss; Should Management be Held Accountable for Shareholder Losses? Contact Johnson Fistel, Globally-Recognized Law Firm July 19, 2022
Biotechnology Gb Sciences Ahead In Digital Transformation in Biopharma Industry Through Its Novel AI-Accelerated Drug Discovery Platform July 19, 2022
Biotechnology Apellis Announces FDA Acceptance and Priority Review of the New Drug Application for Pegcetacoplan for the Treatment of Geographic Atrophy (GA) July 19, 2022